Global Vaccines CMO Data



Global Vaccine CMOs data provides extensive data and analyses of over 150 vaccine-focused contract manufacturing service providers and their manufacturing facilities. It features end-to-end capabilities of small or large-scale manufacturers and provides detailed insights that are available nowhere in the market the goal of assisting market players in advancing their priorities and investments, as well as accessing the competitive landscape across 4 regions- Asia, Europe, North-America, Rest of the World.

It features the worldwide Vaccine CMO’s (Pharmaceutical, Biopharma, Others) capabilities based on various parameters and tracks in-depth data across different stages of manufacturing such as the clinical and commercial scale of productions.

The data is captured around 20 vital metrics including vaccine manufacturer’s name, country, service offerings, manufacturing scale, technology platforms, vaccines manufactured, projects of CMOs, vaccine facility name & location, establishment year, facility size & capacity, annual production, batch size, bioprocessing equipment, bioreactors, expression system, manufacturing process type, regulatory compliance & certifications, sponsors & collaborations, future plans of CMOs and many other parameters. Complete list of parameters is provided in the following section.

The data is underpinned by user-friendly visuals to allow users to filter through within all the parameters to obtain any specific data such as Vaccine CMOs by country, vaccine type, manufacturing scale, regulatory compliance, equipment, service offerings, facility size, expression system, manufacturing process mode among other useful filters.

Outsourcing has become increasingly significant as it offers end-to-end manufacturing solutions and expertise in vaccine manufacturing. North America is seeing the increasing trend of outsourcing for contract manufacturing in the region with highest numbers of CMOs operating across US. Europe has the second highest market for vaccine contract manufacturing with increasing demand for new vaccines and expanding biopharma market. Growing vaccine pipelines and increasing outsourcing of vaccine operations in the APAC region is likely to influence the vaccine CMO market in the coming years.

Pick the right plan!

From evolving customer expectations and emerging technologies to more nimble companies entering industries, businesses today are more at risk for disruption than ever before.
6 Months
  • Access for 6 months
  • Single user
  • Monthly Updates
1 Year
  • Access for 1 year
  • Single User
  • Monthly Updates

Key Parameters

  • Vaccine Manufacturer’s Name
  • Manufacturers Location
  • Facility Establishment Year
  • CMO’s Service Offerings
  • Additional Services Offerings
  • Manufacturing Scale
  • Major Highlights
  • Technology Platforms
  • Vaccines Manufactured
  • Projects
  • Investment (USD Mn)
  • Plant Name & Location
  • Production Capacity & Batch Size
  • Facility Size (Square meters)
  • Bioreactor Capacity
  • Expression System
  • Manufacturing Process Type
  • Bioprocessing Equipment (Include Technology & Service Providers Name)
  • Regulatory Compliance & Certifications
  • Sponsors & Collaborators
  • Expansion Plans & Other Updates

Regions Coverage

Asia, Europe, North America, RoW

Product Types Covered


How This Data Will Benefit?

This data provides easy to comprehend data for over 150 vaccine manufacturers with in-house capabilities and expert service offerings to support you with end-to-end vaccine manufacturing process. We ensure delivery of highly-qualified research as we tap into our database of 62000+ life science professionals curated over a decade.

Vaccine CMOs data provides extensive data and analyses of vaccine-focused contract manufacturing service providers and their manufacturing facilities. Through this data IMAPAC aims to assist organizations to keep track of Vaccine CMOs globally, identify any opportunities for strategic partnership or investments to speed vaccines to market.

Through this data, you are more likely to stay ahead of your competitors by keeping updated track of new and upcoming Vaccine CMOs, expand your knowledge & expertise in biomanufacturing.

Data Methodology

The data is researched and validated using primary and secondary research. The data is collected through multiple scientific and non-scientific sources including live discussions with experts through IMAPAC’s events and research reports, survey polls, company websites, press releases, publicly available information, regulatory database and many more.

We have a database of key decision makers from the biopharma companies across the region. We host industry surveys with bioprocessing leaders of CMOs and Biopharma, and host primary interviews with Heads of Manufacturing, R&D, Process Development Heads and multiple stakeholders in the companies to gather data as well as validate that data using our primary research analysts.

Throughout the year, we keep in touch with the KOLs through telephonic Conversation, with Q&A sessions with high profile biopharma professionals, for example CSO/CTO profiles. Apart from telephonic conversations, we send a list of questions which these experts fill in detail and send back to us.

We have dedicated analysts who gather data. The data included in the data is validated through primary research (interviews, phone calls) with stakeholders which is then validated by IMAPAC’s research analysts to ensure the accuracy of the data.

Key Questions Answered

  • Who are the top Vaccine manufacturers?
  • How big is the vaccine contract manufacturing market?
  • Which region has the largest number of vaccine manufacturers?
  • What are the various manufacturing capabilities of the CMOs in all regions?
  • Which type of vaccines are manufactured in global facilities?
  • How many projects are completed by the Vaccine CMOs?
  • What are the equipment capacities in manufacturing facility, process development labs?
  • Which CMO facilities offers end-to-end services including packaging and logistics?
  • Which are the key existing clients of Vaccine CMOs and their client distribution?
  • What type and model of equipment and technologies are used by CMOs?
  • Who is the technology or service providers of these CMOs?
  • Who are the current partners and investors of CMOs?

Data Sample